title: Age and aging in blood disorders: multiple myeloma.
authors.affiliation: Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
authors.forename: Sonja
authors.initials: S
authors.lastname: Zweegman
authors.affiliation: Department of Hematology, University of Torino, Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Palumbo
authors.affiliation: Department of Hematology, University of Torino, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Bringhen
authors.affiliation: Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands p.sonneveld@erasmusmc.nl.
authors.forename: Pieter
authors.initials: P
authors.lastname: Sonneveld
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy*; D061988:Proteasome Inhibitors / Q000627:therapeutic use; D059039:Standard of Care; D016896:Treatment Outcome
chemical_list: D007155:Immunologic Factors; D061988:Proteasome Inhibitors